TACT is an international non-profit collaboration of groups dedicated to thoracic oncology clinical research. Our worldwide network helps researchers navigate an increasingly complex landscape as understanding of lung cancer and new treatment approaches evolve.
for Cancer Trials
Welcome to the website of TACT, the Thoracic Alliance for Cancer Trials. TACT is a unique opportunity to improve outcomes for patients with thoracic malignancy by facilitating clinical research through a truly global network, harmonisation of governance and operations and fostering a genuine collaboration among groups and with external partners. TACT was established in September 2015 at the IASLC 16th World Conference on Lung Cancer in Denver, Colorado as an international non-profit umbrella organisation for worldwide academic groups who are dedicated to thoracic oncology research. With our global reach, TACT is ideally positioned to navigate the increasingly complex landscape of lung cancer diagnosis and novel treatment approaches by enabling lung cancer researchers worldwide to work together on joint projects and clinical trials.
Paul Mitchell, Board Chair